rfhg_146508.1

Basic information about the TSS

---

TSS ID: rfhg_146508.1 Species: human Chr: chr12		Start: 6870423 End: 6870458 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000474253.1:-406 GeneID: 7167 HGNC/MGI_ID: HGNC:12009 UniProt_ID: Nearer transcript ids and distances:

Gene_name: triosephosphate isomerase 1 Gene_symbol: TPI1 Gene_synonyms: Gene_source: HGNC:12009

TATA-Box annotation

---

Distance to TSS:	2326
Nearest PromoterID:	NM_001258026
Entrez ID:	7167
Nearest Unigene:	Hs.524219
Nearest Refseq:	NM_000365
Nearest Ensembl:	ENSG00000111669
Gene Name:	triosephosphate isomerase 1
Gene Alias:	HEL-S-49|TIM|TPI|TPID
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.555556
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TPI1 p2@TPI1 p3@TPI1 p7@TPI1 p8@TPI1
Sample		p1@TPI1	p2@TPI1	p3@TPI1	p7@TPI1	p8@TPI1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	154.87	0.58	1.56	0.19	3.31
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	160.64	0.61	1.62	0.00	3.24
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	162.81	0.96	1.74	0.19	1.74
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	149.90	1.46	0.62	0.00	3.12
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	169.40	1.12	1.80	0.22	2.47
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	160.67	0.78	1.55	0.19	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	169.51	1.09	1.96	0.00	2.18
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	166.89	1.21	1.45	0.00	3.63
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	160.29	0.21	1.92	0.00	2.14
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	128.68	1.16	1.74	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	103.08	0.40	1.21	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	105.70	0.00	0.00	0.00	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	43.68	4.35	0.64	0.00	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	60.14	3.76	0.75	0.30	4.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	265.88	3.07	0.66	0.22	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	39.48	5.03	0.50	0.25	4.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	233.70	3.06	0.22	0.00	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	45.13	2.95	1.69	0.00	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	255.91	8.53	1.60	0.00	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	272.60	4.06	1.50	0.45	5.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	45.04	4.54	1.07	0.40	3.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	40.91	3.45	0.52	0.17	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	45.63	2.46	0.26	0.65	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	95.61	2.91	0.49	0.24	3.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	257.22	2.58	0.26	0.52	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	281.38	3.48	0.95	0.32	3.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	53.30	3.30	0.00	0.00	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	371.31	3.30	0.47	0.24	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	288.80	3.39	0.81	0.00	4.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	352.52	3.62	0.72	0.00	4.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	47.94	3.35	0.00	0.21	4.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	327.46	5.86	0.39	0.20	3.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	32.29	4.01	0.00	0.00	4.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	60.53	2.80	1.32	0.16	4.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	329.66	3.18	0.93	0.00	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	318.86	4.22	0.57	0.38	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	325.17	2.86	0.61	0.20	2.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	316.33	2.42	1.01	0.00	3.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	290.09	2.70	0.27	0.27	2.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	323.84	1.92	0.24	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	334.07	3.53	0.94	0.24	3.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	40.55	1.76	0.59	0.00	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	270.58	1.27	0.21	0.00	5.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	253.15	2.62	0.17	0.17	3.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	269.84	3.01	0.60	0.00	2.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	265.91	2.09	0.70	0.00	5.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	281.89	3.12	0.48	0.24	4.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	312.06	1.19	0.30	0.30	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	279.35	0.48	0.48	0.24	3.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	246.48	2.43	0.20	0.40	4.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	35.87	1.64	0.41	0.00	6.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	48.70	2.22	0.44	0.00	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	349.80	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	283.18	0.71	0.71	0.71	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	350.60	1.33	0.66	0.00	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	259.23	0.84	2.52	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	41.79	1.38	0.92	0.46	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	337.72	1.94	1.94	0.97	4.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	351.04	3.53	0.00	0.00	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	372.17	1.89	1.57	0.00	5.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	300.35	0.00	0.71	0.00	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	274.23	0.56	2.24	0.00	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	193.46	0.00	1.59	0.00	4.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	222.55	1.36	0.34	0.00	3.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	283.98	1.62	0.65	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	245.65	1.42	0.71	0.00	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	145.48	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	386.98	0.00	15.79	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	323.22	1.46	1.95	0.00	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	275.21	2.98	0.50	0.00	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	345.27	4.69	0.47	0.47	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	337.15	0.33	0.66	0.00	3.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	278.10	1.55	0.93	0.00	4.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	301.46	2.45	1.53	0.31	2.45
Adipocyte - breast, donor1	11376-118A8	28.51	1.11	1.11	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	40.75	0.48	2.09	0.00	1.44
Adipocyte - omental, donor1	11473-119C6	36.51	0.38	0.38	0.00	0.25
Adipocyte - omental, donor2	11474-119C7	242.94	1.49	0.75	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	218.37	0.67	1.00	0.33	0.67
Adipocyte - perirenal, donor1	11476-119C9	179.28	3.83	6.38	0.00	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	30.79	0.00	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	65.03	0.00	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	35.45	0.70	0.52	0.00	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	15.06	0.20	0.00	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	40.92	0.26	0.51	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	33.17	0.00	0.28	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	26.45	0.00	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	136.58	0.08	0.24	0.00	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	29.69	1.29	0.32	0.00	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	31.46	0.00	1.60	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	35.06	0.56	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	59.06	0.00	0.00	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	28.38	0.25	0.25	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	23.89	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	29.84	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	104.53	1.77	1.33	0.44	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	831.19	3.23	5.38	0.36	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	100.63	3.59	3.59	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	28.78	0.18	0.54	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	35.14	3.35	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	26.09	0.00	0.00	0.00	0.62
Anulus Pulposus Cell, donor1	11248-116E6	50.23	1.83	0.46	0.00	0.34
Anulus Pulposus Cell, donor2	11463-119B5	297.07	2.69	1.96	0.00	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	74.58	0.45	1.80	0.00	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	82.05	0.43	1.74	0.00	2.17
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	44.95	0.00	4.28	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	87.29	0.60	1.20	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	69.56	1.26	7.59	0.00	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	61.39	0.66	0.66	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	68.88	0.97	2.92	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	77.19	0.00	1.46	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	42.76	0.00	1.78	0.00	3.56
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	73.44	1.51	1.13	0.00	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	55.88	0.00	1.45	0.00	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	43.88	0.00	5.02	0.00	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	46.62	0.16	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	34.12	1.36	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	55.04	0.30	0.45	0.00	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	65.37	0.00	1.61	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	75.95	0.57	1.51	0.00	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	59.87	0.27	2.14	0.00	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	27.31	0.00	0.98	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	209.15	0.33	0.66	0.00	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	70.84	1.20	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	62.61	1.03	1.03	0.00	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	46.14	0.00	0.00	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	73.78	0.49	1.94	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	84.62	1.14	2.66	0.38	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	42.40	2.42	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	70.68	0.57	0.57	0.00	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	47.89	0.43	0.86	0.21	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	60.65	1.29	1.03	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	78.36	1.88	2.35	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	46.30	0.96	0.32	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	64.21	0.00	0.71	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	61.42	1.75	1.75	0.00	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	46.06	0.30	1.20	0.00	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	61.78	0.00	3.56	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	82.39	0.00	2.54	0.00	2.54
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	42.79	0.00	1.27	0.00	1.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	49.56	0.64	3.81	0.00	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	65.59	0.43	1.73	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	79.38	0.64	1.91	0.00	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	65.83	1.16	1.74	0.00	1.74
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	59.52	1.89	0.94	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	72.05	0.17	0.85	0.00	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	60.23	0.00	2.32	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	6.34	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	78.05	0.64	2.14	0.00	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	68.59	0.00	2.41	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	76.54	2.19	2.92	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	74.71	0.23	1.84	0.00	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	28.05	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	52.37	0.76	0.51	0.00	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	44.59	0.83	2.89	0.00	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	56.61	0.92	1.22	0.00	1.84
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	75.05	0.96	1.43	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	51.44	0.22	1.77	0.00	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	30.52	0.00	3.05	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	84.74	0.55	0.55	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	49.25	1.06	1.32	0.00	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	45.43	1.09	2.54	0.00	1.45
Astrocyte - cerebellum, donor1	11500-119F6	95.92	0.49	0.25	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	453.06	1.20	1.88	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	57.47	1.05	1.05	0.21	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	41.13	0.35	0.35	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	53.71	0.97	2.59	0.00	1.94
Astrocyte - cerebral cortex, donor3	11392-118C6	69.06	0.89	0.89	0.00	1.04
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	68.58	11.47	1.38	0.69	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	60.01	6.26	0.50	0.38	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	65.66	6.94	0.91	0.57	0.46
Basophils, donor1	12241-129G9	27.72	0.00	0.52	0.00	1.05
Basophils, donor2	12242-129H1	24.89	0.72	0.00	0.00	0.00
Basophils, donor3	12243-129H2	103.19	0.00	0.15	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	44.63	0.65	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	715.95	0.46	3.66	0.46	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	197.71	1.26	9.41	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	748.62	0.62	5.20	0.00	1.66
Bronchial Epithelial Cell, donor6	11461-119B3	399.32	0.46	3.91	0.23	1.61
Bronchial Epithelial Cell, donor7	11769-123I5	27.71	0.54	2.34	0.00	1.26
Burkitt's lymphoma cell line:DAUDI	10422-106C8	39.57	0.82	0.21	0.00	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	115.75	2.56	0.23	0.23	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	26.54	0.32	0.32	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	20.29	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	10.95	0.19	1.30	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	12.73	0.22	0.88	0.00	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	27.46	0.00	0.00	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	21.23	0.00	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	22.35	0.33	0.00	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	21.68	0.00	0.29	0.00	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	13.28	0.00	0.91	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	14.69	0.71	0.00	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	20.76	0.17	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	12.70	0.00	0.83	0.00	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	17.11	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	18.60	0.00	0.20	0.00	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	15.67	0.00	0.89	0.00	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	24.16	0.00	0.22	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	24.58	0.00	0.94	0.23	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	13.20	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	39.94	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	17.55	0.00	0.74	0.00	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	12.77	0.00	0.00	0.00	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	22.49	0.00	0.21	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	19.68	0.23	1.83	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	9.95	0.00	0.00	0.00	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	18.33	0.00	0.87	0.00	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	22.33	0.27	0.54	0.00	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	19.37	0.00	0.52	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	18.52	0.00	0.42	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	15.62	0.18	0.18	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	13.03	0.00	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	15.79	0.00	0.88	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	13.95	0.00	0.17	0.00	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	17.10	0.00	0.37	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	30.39	0.22	0.65	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	14.33	0.41	0.00	0.00	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	20.17	0.00	0.00	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	25.06	0.23	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	32.48	0.22	1.74	0.00	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	42.27	0.00	0.69	0.00	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	40.94	0.00	0.43	0.00	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	40.49	0.00	0.31	0.00	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	42.44	0.52	0.52	0.00	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	18.06	0.00	0.67	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	48.99	0.00	0.51	0.00	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	39.08	0.66	1.76	0.00	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	40.42	0.00	0.21	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	12.19	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	12.88	0.00	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	6.21	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	20.26	1.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	10.72	0.54	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	14.74	0.70	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	13.33	0.78	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	14.50	0.00	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	3.29	0.82	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	7.25	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	6.56	0.00	0.00	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	23.84	0.00	0.00	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	28.76	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	7.03	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	21.35	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	46.97	0.38	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	42.62	0.00	0.68	0.00	0.90
CD4+ T Cells, donor1	11225-116C1	8.21	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	7.35	1.84	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	9.45	0.30	0.61	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	38.29	0.26	1.02	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	40.65	0.45	0.22	0.00	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	40.53	0.00	0.29	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	7.59	0.47	0.47	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	18.26	0.00	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	42.05	1.88	0.43	0.00	1.16
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	40.33	1.19	1.69	0.00	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	40.95	1.77	0.97	0.00	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	17.93	0.45	0.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	21.66	0.35	0.70	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	18.48	0.88	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	46.38	0.84	0.42	0.00	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	32.41	0.62	0.42	0.00	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	44.44	1.34	1.00	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	5.17	0.54	0.82	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	10.72	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	10.76	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	82.52	2.23	1.11	0.00	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	43.11	1.08	0.22	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	31.10	2.10	0.21	0.21	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	12.64	0.00	0.51	0.00	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	21.23	1.30	0.43	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	9.59	0.44	1.31	0.00	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	14.35	1.48	0.49	0.00	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	17.54	0.00	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	18.15	0.00	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	24.09	0.55	0.00	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	21.59	0.25	0.25	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	13.86	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	13.97	1.43	1.07	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	13.85	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	7.20	1.64	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	8.26	0.38	0.00	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	6.82	0.76	0.25	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	72.49	0.23	1.15	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	57.51	0.24	0.24	0.00	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	55.54	0.00	0.27	0.00	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	361.45	0.30	1.20	0.00	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	43.92	0.48	0.00	0.00	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	60.48	0.91	0.23	0.00	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	86.91	0.22	1.09	0.00	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	90.28	0.53	0.79	0.00	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	79.97	0.00	1.17	0.00	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	112.90	0.00	0.60	0.00	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	95.87	1.16	0.87	0.00	2.03
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	100.71	0.27	1.87	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	70.92	0.44	0.44	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	72.41	0.00	0.00	0.00	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	51.47	0.75	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	72.39	0.72	1.08	0.00	1.80
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	59.56	0.58	0.29	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	55.62	0.00	0.00	0.24	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	105.21	0.63	0.95	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	102.11	0.62	0.31	0.00	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	83.03	0.00	0.96	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	83.76	0.38	1.15	0.00	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	98.92	0.00	0.39	0.00	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	90.77	0.76	0.00	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	69.86	1.61	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	48.26	2.10	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	46.08	3.01	0.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	69.45	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	70.65	0.49	0.49	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	619.50	2.74	0.53	0.63	0.21
Chondrocyte - de diff, donor1	11261-116G1	42.99	0.00	0.00	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	90.27	1.78	0.71	0.00	1.07
Chondrocyte - de diff, donor3	11410-118E6	33.11	0.68	1.14	0.00	0.57
Chondrocyte - re diff, donor2	11339-117F7	66.25	0.00	0.00	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	86.14	6.07	2.43	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	35.69	0.46	1.38	0.11	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	33.77	0.21	2.78	0.00	1.71
Ciliary Epithelial Cells, donor3	11399-118D4	51.68	0.35	1.15	0.00	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	18.07	3.58	0.09	0.28	0.09
Corneal Epithelial Cells, donor1	11526-119I5	42.60	0.22	0.44	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	86.46	1.14	1.14	1.14	2.28
Corneal Epithelial Cells, donor3	11687-122I4	54.19	0.00	0.26	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	36.49	0.00	0.50	0.00	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	39.11	0.32	0.32	0.00	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	0.00	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	31.86	0.11	1.08	0.00	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	7.17	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	9.14	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	7.74	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	88.89	0.17	0.00	0.00	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	385.51	0.59	0.59	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	71.55	0.00	0.28	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	77.46	0.00	0.00	0.00	0.79
Endothelial Cells - Artery, donor1	11264-116G4	267.02	0.00	0.00	0.00	0.87
Endothelial Cells - Artery, donor2	11341-117F9	104.46	0.00	2.35	0.00	1.41
Endothelial Cells - Artery, donor3	11413-118E9	67.67	0.18	1.23	0.00	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	26.15	0.22	0.22	0.00	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	19.47	0.91	0.00	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	25.37	0.56	0.28	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	41.60	0.30	0.00	0.00	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	40.61	0.00	2.08	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	66.50	0.14	0.14	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	61.22	0.40	0.00	0.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	70.23	0.52	3.14	0.00	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	57.15	0.00	0.37	0.00	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	60.40	0.00	0.87	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	60.21	0.12	0.49	0.00	0.12
Endothelial Cells - Vein, donor1	11267-116G7	43.23	0.00	2.28	0.00	2.28
Endothelial Cells - Vein, donor2	11344-117G3	74.04	0.00	1.40	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	456.26	0.31	1.88	0.16	0.31
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	24.75	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	10.70	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	60.59	1.47	0.00	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	112.33	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	55.42	2.05	0.00	0.82	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	372.15	2.85	2.08	0.44	9.96
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	82.99	0.54	1.08	0.00	4.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	44.87	0.61	0.49	0.00	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	49.13	1.09	0.41	0.55	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	45.88	0.95	1.79	0.32	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	29.25	0.26	0.26	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	55.81	0.00	1.99	0.00	1.00
Fibroblast - Cardiac, donor1	11268-116G8	562.50	3.63	2.72	0.00	3.18
Fibroblast - Cardiac, donor2	11345-117G4	140.22	0.76	1.52	0.00	3.79
Fibroblast - Cardiac, donor3	11417-118F4	80.12	1.26	1.89	0.00	0.95
Fibroblast - Cardiac, donor4	11452-119A3	21.82	0.30	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	261.42	0.38	0.89	0.00	0.63
Fibroblast - Cardiac, donor6	11460-119B2	263.02	0.45	1.21	0.00	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	68.20	0.40	0.27	0.00	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	47.46	0.00	1.29	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	26.37	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	54.43	0.23	0.23	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	15.77	0.85	0.00	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	288.31	0.70	0.94	0.23	0.47
Fibroblast - Dermal, donor2	11346-117G5	78.77	0.47	0.47	0.00	0.94
Fibroblast - Dermal, donor3	11418-118F5	38.80	0.24	0.24	0.00	0.73
Fibroblast - Dermal, donor4	11450-119A1	351.35	0.34	1.36	0.00	0.68
Fibroblast - Dermal, donor5	11454-119A5	423.75	0.00	1.57	0.00	1.05
Fibroblast - Dermal, donor6	11458-119A9	426.36	0.65	1.95	0.00	1.46
Fibroblast - Gingival, donor1	11237-116D4	53.93	0.00	0.21	0.21	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	44.80	1.31	0.79	0.00	1.83
Fibroblast - Gingival, donor2	11318-117D4	51.13	0.13	2.90	0.00	1.45
Fibroblast - Gingival, donor3	11394-118C8	177.13	0.58	0.29	0.00	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	18.70	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	18.85	0.35	0.35	0.00	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	58.31	0.16	0.78	0.00	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	69.51	0.54	1.35	0.00	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	21.53	0.35	0.00	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	48.85	0.73	0.73	0.00	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	62.86	0.82	1.09	0.00	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	50.68	0.22	0.88	0.00	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	24.36	0.73	0.00	0.00	0.44
Fibroblast - Lung, donor1	11270-116H1	40.78	0.00	1.36	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	40.29	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	118.81	0.63	1.48	0.00	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	111.62	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	173.43	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	42.54	0.56	0.00	0.00	0.56
Fibroblast - Mammary, donor1	11540-120B1	47.50	0.41	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	75.89	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	50.24	0.19	0.39	0.00	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	42.62	0.46	0.30	0.00	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	28.46	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	87.39	0.00	0.00	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	43.47	0.27	2.43	0.00	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	30.62	0.23	0.46	0.00	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	70.85	1.11	0.88	0.11	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	31.49	0.00	0.20	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	46.11	0.00	0.67	0.00	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	73.93	0.40	0.79	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	53.18	0.00	0.99	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	48.67	1.95	0.36	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	88.89	2.37	0.20	0.20	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	65.29	0.90	0.30	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	91.11	1.51	0.54	0.11	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	55.17	1.27	0.51	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	51.85	0.49	0.49	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	45.72	0.60	0.00	0.20	0.40
Fibroblast - skin normal, donor2	11561-120D4	437.81	0.60	0.60	0.10	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	82.21	0.30	1.21	0.00	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	60.15	1.66	0.58	0.08	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	23.08	0.68	0.34	0.17	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	45.98	0.99	0.66	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	413.94	1.07	1.07	0.00	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	94.80	1.69	0.34	0.00	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	549.34	0.47	3.61	0.00	3.14
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1196.63	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	29.63	1.74	2.61	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	42.99	0.00	0.17	0.00	1.39
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	40.08	0.52	0.00	0.00	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	29.89	0.26	0.51	0.00	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	184.50	3.83	4.59	0.00	5.36
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	200.35	3.83	7.02	0.00	9.57
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	125.23	3.99	3.14	0.57	8.84
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	51.57	8.27	0.55	0.28	24.54
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	50.23	7.99	1.14	1.83	14.84
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	80.84	5.94	1.39	0.99	9.91
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	45.99	3.44	1.32	0.00	27.23
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	37.18	2.61	0.33	0.98	10.11
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	126.92	7.52	0.44	2.65	13.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	85.36	11.16	2.40	2.26	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	73.52	3.82	1.48	0.86	1.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	108.79	9.94	1.88	1.07	3.76
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	65.04	3.47	0.37	0.50	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	57.17	4.84	0.69	0.83	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	85.59	2.44	1.42	0.00	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	42.44	2.05	0.68	0.46	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	55.18	3.11	1.37	0.37	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	87.87	7.43	1.09	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	53.78	2.66	1.48	0.59	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	35.77	2.86	0.95	0.64	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	74.62	3.35	0.89	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	57.26	2.82	1.81	1.01	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	50.55	2.88	0.85	0.51	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	34.67	0.62	0.18	0.27	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	64.41	5.10	0.62	1.35	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	76.34	4.27	0.68	1.02	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	77.35	2.99	0.55	0.77	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	45.92	2.83	0.58	1.00	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	77.18	1.63	0.82	0.20	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	93.66	4.95	1.03	1.03	1.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	50.38	6.34	1.04	1.61	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	58.70	3.50	1.33	0.67	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	56.87	3.31	1.10	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	61.50	2.21	0.74	0.61	1.11
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	63.54	5.51	2.11	0.81	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	35.28	3.53	0.64	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	77.60	5.59	0.95	1.33	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	87.47	5.69	0.32	0.63	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	66.60	3.34	1.52	1.22	3.34
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	67.11	5.75	0.94	1.15	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	78.38	7.68	0.88	0.88	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	67.33	3.09	0.84	1.68	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	26.85	0.28	0.93	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	46.53	1.07	1.07	0.00	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	34.58	0.15	0.46	0.00	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	32.77	0.78	0.65	0.00	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	41.47	0.81	0.54	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	37.79	0.55	2.40	0.00	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	38.82	2.19	0.66	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	29.75	0.99	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	46.70	0.79	0.66	0.13	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	40.55	1.21	0.81	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	31.01	4.07	0.00	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	117.84	4.38	1.79	0.60	1.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	60.40	2.62	1.39	0.31	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	63.01	4.71	1.23	0.82	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	157.72	3.76	1.88	0.00	5.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	186.77	3.96	1.70	0.00	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	108.84	6.00	3.69	0.92	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	113.84	4.95	4.95	0.00	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	89.74	2.71	2.71	0.00	3.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	27.28	3.21	1.60	0.00	8.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	97.37	0.00	3.48	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	89.51	1.95	3.25	0.00	3.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	77.42	0.82	3.71	0.00	4.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	93.30	3.33	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	93.68	0.84	3.36	0.84	2.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	78.12	2.29	2.94	0.33	3.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	76.33	5.03	0.84	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	114.51	3.18	2.86	0.95	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	90.01	4.42	2.38	0.34	2.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	96.05	4.18	2.09	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	130.00	12.60	4.01	1.72	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	103.30	4.74	4.44	0.30	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	99.95	1.69	3.39	0.00	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	123.02	1.24	4.97	0.83	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	123.35	2.99	2.30	0.69	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	94.83	0.00	5.27	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	91.87	2.31	3.08	0.38	4.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	110.50	2.61	2.28	0.00	3.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	118.38	6.02	4.68	0.67	8.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	102.10	5.39	3.85	0.77	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	81.13	3.42	1.71	0.68	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	32.30	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	70.78	5.19	1.89	0.94	3.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	72.42	2.41	1.81	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	87.49	4.07	2.03	0.51	4.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	84.55	4.79	1.60	0.00	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	76.96	3.95	1.48	0.99	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	49.58	4.72	10.62	0.00	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	78.77	4.08	4.08	0.58	4.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	43.01	2.63	1.32	0.44	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	54.25	4.24	3.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	103.86	1.19	4.18	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	111.12	4.37	2.91	1.46	3.40
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	53.64	0.00	1.14	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	55.30	0.83	1.25	0.00	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	119.19	2.25	1.12	0.00	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	24.10	0.32	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	40.52	0.42	1.25	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	170.81	0.58	1.39	0.12	1.86
Hep-2 cells mock treated, biol_rep2	11899-125E9	102.29	0.17	1.52	0.00	1.69
Hep-2 cells mock treated, biol_rep3	11900-125F1	98.28	0.23	2.50	0.00	1.82
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	180.58	0.22	3.17	0.22	1.75
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	123.14	0.64	1.93	0.43	2.15
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	107.21	0.65	1.51	0.00	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	122.54	0.75	1.74	0.12	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	101.90	0.51	1.37	0.00	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	90.99	0.64	4.16	0.00	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	209.86	0.56	1.12	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	83.10	0.43	0.87	1.30	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	2.64	0.00	2.64	0.00	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	48.68	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	43.59	0.73	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	46.68	0.00	2.10	0.00	0.35
Hepatocyte, donor1	11523-119I2	29.05	0.00	2.42	0.00	0.00
Hepatocyte, donor2	11603-120I1	40.94	0.00	1.08	0.00	1.08
Hepatocyte, donor3	11684-122I1	31.90	0.00	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	40.47	5.87	3.26	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	26.22	0.17	0.35	0.00	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	70.25	3.70	0.41	0.55	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	76.41	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	55.38	2.77	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	117.63	7.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	11.87	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	48.70	0.00	5.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	68.56	13.71	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	30.86	1.62	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	61.69	1.67	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	79.87	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	79.41	1.32	3.97	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	63.19	5.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	110.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	56.69	2.52	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	61.86	0.00	3.09	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	46.51	2.58	0.65	0.65	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	66.01	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	49.71	1.63	2.44	0.00	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	63.81	3.36	0.84	0.84	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	49.83	0.00	3.21	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	61.86	3.69	1.85	0.92	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	49.09	1.42	1.89	0.00	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	60.77	0.91	2.72	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	50.58	2.15	1.08	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	67.33	2.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	98.58	0.00	0.00	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	46.55	1.28	0.64	0.00	3.19
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	74.73	1.82	1.82	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	142.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	52.84	0.71	1.43	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	43.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	51.55	0.62	2.47	0.00	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	64.97	1.76	3.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	59.72	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	58.41	0.70	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	70.82	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	97.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	59.29	0.00	2.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	51.75	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	55.75	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	38.40	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	34.64	0.00	0.00	0.00	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	62.69	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	57.07	0.92	1.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	45.38	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	0.00	6.21	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	34.89	2.11	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	41.94	0.98	0.24	0.08	0.00
Keratinocyte - epidermal, donor2	11349-117G8	40.41	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	49.88	0.47	1.04	0.00	0.85
Keratinocyte - oral, donor1	11251-116E9	37.23	0.57	0.34	0.00	0.23
Keratocytes, donor1	11527-119I6	54.33	0.34	0.00	0.00	0.34
Keratocytes, donor2	11607-120I5	63.28	0.00	0.00	0.00	2.34
Keratocytes, donor3	11688-122I5	32.80	0.59	0.20	0.00	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	4.40	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	129.45	2.16	1.08	0.00	2.16
Lens Epithelial Cells, donor2	11609-120I7	44.98	3.23	0.23	0.46	0.23
Lens Epithelial Cells, donor3	11690-122I7	39.15	0.91	0.10	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	29.41	0.12	0.71	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	31.81	0.00	0.28	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	28.18	0.00	0.79	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	34.95	0.00	0.54	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	33.41	0.00	0.63	0.00	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	30.62	0.00	1.08	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	44.73	0.00	0.41	0.41	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	44.24	0.25	1.01	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	27.87	0.28	0.84	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	36.39	0.00	1.58	0.00	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	39.55	0.19	0.58	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	34.25	0.00	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	36.58	0.35	1.05	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	38.16	0.24	0.95	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	31.18	0.00	0.55	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	37.88	0.31	0.92	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	49.88	0.31	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	34.40	0.00	0.18	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	26.33	0.66	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	44.81	0.00	0.00	0.00	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	42.57	0.00	0.25	0.00	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	36.86	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	43.09	0.00	0.27	0.00	1.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	29.37	0.00	1.97	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	41.99	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	45.44	0.42	0.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	34.74	0.15	0.75	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	52.28	0.00	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	43.46	0.38	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	31.60	0.00	0.42	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	29.07	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	40.36	0.33	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	31.22	0.00	0.74	0.00	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	39.24	0.00	0.74	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	39.53	0.49	0.25	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	30.25	0.00	0.69	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	36.99	0.32	0.32	0.00	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	38.95	0.00	0.30	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	35.97	0.00	0.42	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	36.98	0.00	1.07	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	57.69	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	39.06	0.16	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	45.48	0.36	0.72	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	41.16	1.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	42.38	0.00	0.47	0.00	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	31.43	0.00	0.25	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	38.68	0.00	0.51	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	162.31	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	61.18	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	53.70	0.77	0.77	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	42.31	0.00	1.48	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	73.20	1.69	3.81	0.00	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	40.09	0.70	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	57.91	0.00	1.87	0.00	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	59.26	0.52	3.61	0.00	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	40.44	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	46.60	1.36	2.04	0.00	1.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	57.29	0.87	1.45	0.00	3.20
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	45.92	1.80	0.45	0.00	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	41.73	0.68	1.22	0.00	0.95
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	64.19	1.03	3.08	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	36.70	0.35	2.47	0.00	2.12
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	44.64	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	52.47	0.51	2.55	0.00	4.08
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	33.88	0.80	1.07	0.27	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	46.29	0.57	2.46	0.00	2.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	65.04	0.61	2.45	0.00	4.29
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	44.85	1.63	1.63	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	47.48	0.62	2.29	0.00	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	55.21	0.28	2.24	0.00	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	32.97	2.06	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	47.32	0.87	3.77	0.29	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	59.19	0.30	1.79	0.30	1.79
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	43.71	0.00	2.77	0.55	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	47.72	2.47	1.77	0.00	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	57.53	1.48	2.95	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	64.47	1.15	5.76	0.00	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	52.57	1.54	1.54	0.00	2.30
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	65.11	1.13	5.10	0.00	6.23
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	42.66	0.00	0.82	0.00	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	55.58	1.36	2.26	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	73.97	1.44	6.46	0.72	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	48.55	1.49	2.24	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	54.25	1.11	4.09	0.00	2.23
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	69.78	1.72	2.15	0.43	3.02
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	52.23	1.71	1.71	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	52.98	1.33	2.33	0.33	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	77.22	0.00	1.21	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	43.37	1.42	2.13	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	54.31	1.03	3.09	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	84.81	0.54	1.61	0.00	2.15
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	45.79	0.67	1.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	51.49	0.37	3.70	0.37	1.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	67.45	0.00	1.16	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	33.85	1.06	3.17	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	46.02	0.80	3.20	0.40	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	75.59	0.00	1.45	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	49.82	0.77	1.53	0.00	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	46.86	0.99	1.48	0.00	2.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	66.81	0.94	2.82	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	56.32	0.50	0.50	0.00	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	42.36	3.60	1.80	0.00	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	63.68	1.72	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	44.98	1.78	2.23	0.00	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	31.28	0.78	1.56	0.00	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	78.51	1.98	4.62	0.00	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	59.16	1.04	5.19	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	45.51	0.44	0.88	0.00	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	80.51	1.12	3.35	0.00	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	38.86	0.44	1.32	0.00	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	36.26	0.77	3.86	0.00	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	67.35	1.52	3.54	0.00	3.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	44.22	0.96	1.44	0.00	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	36.57	1.99	1.99	0.40	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	60.76	0.61	1.82	0.00	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	76.09	1.38	0.69	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	50.92	0.38	5.32	0.00	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	83.14	0.52	4.65	0.52	3.10
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	319.86	1.21	1.81	0.00	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	51.97	0.32	2.85	0.32	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	67.17	1.07	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	73.56	0.57	2.87	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	57.08	1.03	1.54	0.00	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	76.39	0.71	2.12	0.71	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	74.34	1.13	1.70	0.00	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	50.34	1.25	3.74	0.00	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	86.92	0.00	4.70	0.00	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	367.86	1.25	1.25	0.42	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	47.39	0.46	1.86	0.00	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	78.95	2.01	3.35	0.00	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	60.41	1.60	1.07	0.00	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	54.15	2.02	3.64	0.00	2.42
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	84.43	0.92	2.75	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	69.35	0.00	4.45	0.00	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	50.15	1.71	2.85	0.00	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	90.49	3.07	4.60	0.00	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	167.98	1.09	3.28	0.55	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	55.68	0.45	4.01	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	61.61	1.82	0.78	0.26	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	96.15	2.65	6.63	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	22.86	4.16	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	34.87	0.68	0.23	0.00	0.46
Macrophage - monocyte derived, donor2	11313-117C8	24.04	0.00	0.37	0.00	0.55
Macrophage - monocyte derived, donor3	11389-118C3	56.63	0.00	0.79	0.00	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	51.51	0.00	1.06	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	41.36	0.00	0.79	0.16	0.32
Mallassez-derived cells, donor3	11930-125I4	59.49	0.28	0.28	0.00	0.42
Mammary Epithelial Cell, donor1	11273-116H4	32.38	1.00	0.10	0.00	0.20
Mammary Epithelial Cell, donor2	11350-117G9	60.23	0.87	0.29	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	75.58	2.00	0.75	0.25	0.25
Mast cell - stimulated, donor1	11487-119E2	12.88	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	23.47	0.00	0.11	0.11	0.43
Mast cell, donor2	11565-120D8	15.75	0.59	0.00	0.30	0.30
Mast cell, donor3	11566-120D9	11.03	0.45	0.23	0.00	0.00
Mast cell, donor4	11567-120E1	20.03	0.35	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	33.05	0.22	0.22	0.00	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	54.28	0.00	0.00	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	41.99	0.11	0.92	0.00	0.57
Mast cell, expanded, donor8	11941-126A6	29.12	0.33	0.00	0.00	0.67
Melanocyte - dark, donor1	11502-119F8	39.40	0.00	0.20	0.00	0.20
Melanocyte - dark, donor2	11582-120F7	92.75	0.00	1.38	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	31.73	0.14	0.07	0.00	0.14
Melanocyte - light, donor1	11274-116H5	28.21	0.71	0.00	0.00	0.24
Melanocyte - light, donor2	11351-117H1	41.63	0.00	1.36	0.00	1.36
Melanocyte - light, donor3	11423-118G1	24.28	1.73	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	45.19	0.52	0.94	0.00	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	41.42	0.27	1.61	0.00	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	17.41	0.00	0.27	0.00	0.27
Meningeal Cells, donor1	11493-119E8	98.26	0.12	0.12	0.00	0.12
Meningeal Cells, donor2	11573-120E7	359.60	0.44	0.88	0.00	0.00
Meningeal Cells, donor3	11654-122E7	58.03	1.30	0.57	0.16	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	92.39	0.57	0.29	0.00	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	14.59	0.50	0.30	0.10	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	43.37	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	61.48	1.31	2.62	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	47.36	0.00	0.72	0.00	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	22.66	0.21	0.21	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	30.16	0.00	0.50	0.00	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	81.31	0.44	0.66	0.00	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	68.68	0.00	2.19	0.00	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	81.64	0.41	2.05	0.00	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	83.24	1.94	0.55	0.28	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	47.95	0.74	0.74	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	51.45	3.42	0.26	0.39	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	29.38	0.00	0.89	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	16.35	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	122.96	1.28	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	73.72	0.35	1.77	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	86.31	3.44	0.63	0.31	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	599.42	0.00	1.45	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	42.43	2.12	0.53	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	18.52	2.50	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	27.61	0.43	0.51	0.00	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	28.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	53.93	0.25	1.23	0.00	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	32.98	0.00	0.00	0.00	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	46.18	0.00	1.24	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	28.00	0.21	0.21	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	50.30	0.00	0.75	0.00	1.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	31.65	0.00	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	46.13	0.00	1.02	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	30.89	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	28.32	0.00	0.88	0.00	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	44.45	0.38	0.76	0.00	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	14.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	22.71	0.21	0.85	0.00	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	22.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	19.67	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	15.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	25.09	0.25	2.51	0.00	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	28.76	0.00	0.48	0.00	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	9.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	27.17	0.00	1.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	23.35	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	19.36	0.00	0.00	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	23.60	0.00	0.86	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	18.01	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	19.49	0.00	0.22	0.00	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	20.79	0.00	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	19.57	0.27	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	30.29	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	26.17	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	27.39	0.48	0.96	0.00	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	34.82	0.00	0.40	0.00	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	19.20	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	40.55	0.00	0.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	57.37	0.88	1.31	0.00	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	23.18	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	49.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	68.92	0.25	2.23	0.00	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	29.92	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	41.99	2.21	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	88.55	0.00	2.05	0.00	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	104.59	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	60.72	0.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	94.27	0.84	3.65	0.00	3.09
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	35.74	0.42	1.25	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	64.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	72.10	0.60	3.62	0.00	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	30.89	0.00	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	44.33	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	23.33	0.00	2.28	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	262.82	0.41	0.55	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	65.31	0.52	3.63	0.00	1.30
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	22.74	0.00	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	25.41	0.64	0.64	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	45.90	1.07	1.33	0.00	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	46.40	0.60	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	30.37	0.85	0.85	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	71.67	0.32	1.91	0.00	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	37.15	0.22	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	36.78	0.76	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	66.20	1.14	0.28	0.00	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	42.03	0.00	0.00	0.00	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	29.98	1.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	37.64	0.88	1.18	0.00	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	44.69	0.00	0.58	0.00	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	51.93	0.82	1.65	0.00	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	36.33	0.89	0.30	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	48.97	0.00	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	26.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	45.01	0.00	0.33	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	29.45	0.00	0.00	0.00	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	26.29	0.20	0.20	0.00	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	23.28	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	33.80	0.00	0.00	0.00	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	40.48	0.00	0.00	0.00	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	37.32	0.11	0.90	0.00	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	33.15	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	23.45	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	44.36	0.00	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	36.36	0.00	1.01	0.00	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	26.98	0.00	1.69	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	106.23	1.36	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	38.78	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	48.59	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	16.61	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	536.76	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	238.16	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	95.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	47.83	0.43	0.22	0.22	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	31.36	1.05	0.52	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	184.23	1.33	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	134.81	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	324.57	0.19	0.57	0.00	2.09
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	38.30	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	143.47	2.04	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	369.37	1.84	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	122.63	0.84	0.00	0.00	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	191.06	0.46	0.23	0.00	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	105.12	1.35	0.00	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	23.97	0.63	0.00	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	190.60	0.99	0.50	0.00	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	128.03	0.00	0.27	0.00	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	140.77	2.04	0.91	0.00	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	13.06	0.98	0.16	0.00	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	22.78	0.55	0.73	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	128.37	0.53	1.06	0.00	2.65
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	89.45	1.20	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	19.03	0.33	0.00	0.33	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	80.82	1.63	0.00	0.00	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	15.52	0.35	0.18	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	105.48	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	68.04	0.46	0.00	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	107.97	0.96	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	106.23	0.69	0.00	0.00	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	166.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	20.05	0.00	0.00	0.00	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	85.95	0.85	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	64.80	0.24	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	131.35	0.86	0.43	0.00	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	0.00	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	81.64	0.67	0.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	9.02	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	26.59	1.19	0.40	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	110.51	1.86	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	124.48	0.38	0.00	0.00	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	17.60	1.96	0.00	0.00	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	44.01	1.31	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.00	0.00	0.00	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	101.42	0.00	0.00	0.00	2.65
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	105.05	1.99	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	99.70	0.50	0.00	0.00	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	71.97	0.38	0.38	0.00	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	129.14	0.91	0.91	0.00	1.81
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	21.44	0.88	0.22	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	95.55	1.36	0.68	0.00	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	102.43	1.83	0.00	0.00	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	62.95	1.89	0.00	0.00	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	52.96	0.30	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	88.61	0.00	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	43.08	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	60.87	1.24	0.99	0.12	0.87
Myoblast, donor2	11322-117D8	57.15	0.58	2.30	0.00	0.77
Myoblast, donor3	11398-118D3	54.82	1.35	0.00	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	107.26	2.48	0.58	0.44	0.58
Natural Killer Cells, donor1	11230-116C6	11.99	0.00	0.00	0.00	0.31
Natural Killer Cells, donor2	11311-117C6	8.14	0.30	0.00	0.00	0.60
Natural Killer Cells, donor3	11387-118C1	11.04	0.00	0.55	0.00	0.18
Neural stem cells, donor1	11275-116H6	22.50	0.00	0.36	0.00	0.36
Neural stem cells, donor2	11352-117H2	11.55	3.85	1.93	0.00	0.00
Neurons, donor1	11494-119E9	38.69	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	22.68	1.76	0.22	0.00	0.00
Neurons, donor3	11655-122E8	24.66	0.82	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	5.57	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	5.80	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	5.50	0.00	0.61	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	41.56	0.95	0.36	0.12	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	8.47	2.28	0.33	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	80.42	2.21	2.01	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	60.57	3.30	0.96	0.00	0.83
Olfactory epithelial cells, donor2	11934-125I8	48.06	2.32	2.03	0.29	1.30
Olfactory epithelial cells, donor3	11935-125I9	27.81	1.02	0.45	0.11	0.34
Olfactory epithelial cells, donor4	11936-126A1	64.87	4.38	1.07	0.58	1.07
Oligodendrocyte - precursors, donor1	11496-119F2	46.94	0.00	0.60	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	71.89	6.17	0.64	0.43	0.64
Osteoblast - differentiated, donor2	11353-117H3	26.29	1.14	0.00	0.00	2.29
Osteoblast - differentiated, donor3	11425-118G3	13.66	0.62	2.48	0.62	0.62
Osteoblast, donor1	11277-116H8	96.94	0.98	0.78	0.59	0.59
Osteoblast, donor2	11354-117H4	66.72	1.40	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	178.44	3.02	1.78	0.18	1.96
Pancreatic stromal cells, donor1	11249-116E7	33.19	0.25	0.34	0.08	0.51
Pericytes, donor1	11491-119E6	189.38	1.67	0.11	0.11	0.56
Pericytes, donor2	11571-120E5	304.91	1.81	0.45	0.00	0.23
Pericytes, donor3	11652-122E5	263.26	5.49	2.64	1.22	2.24
Perineurial Cells, donor1	11499-119F5	114.72	3.16	0.45	0.45	0.23
Perineurial Cells, donor2	11579-120F4	61.83	0.18	0.28	0.00	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	16.89	0.00	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	13.71	0.00	1.22	0.00	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	11.00	0.52	0.52	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	53.33	0.24	0.48	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	46.57	3.33	0.00	0.00	2.22
Placental Epithelial Cells, donor3	11427-118G5	31.81	0.59	0.98	0.20	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	320.25	2.22	2.22	0.32	4.11
Preadipocyte - breast, donor1	11467-119B9	32.45	1.13	0.00	0.38	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	37.98	0.26	0.26	0.00	0.13
Preadipocyte - breast, donor2	11328-117E5	41.65	1.80	0.68	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	51.89	3.30	1.49	0.32	0.43
Preadipocyte - omental, donor2	11329-117E6	27.06	0.87	0.00	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	35.67	0.29	0.57	0.00	0.43
Preadipocyte - perirenal, donor1	11469-119C2	716.55	7.87	4.92	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	94.90	0.92	0.00	0.00	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	77.91	0.18	1.95	0.18	1.77
Preadipocyte - subcutaneous, donor3	11428-118G6	69.65	0.85	2.21	0.17	1.87
Preadipocyte - visceral, donor1	11280-116I2	52.16	1.21	0.37	0.09	0.56
Preadipocyte - visceral, donor2	11357-117H7	61.20	0.92	0.00	0.00	1.84
Preadipocyte - visceral, donor3	11429-118G7	453.91	0.63	2.40	0.00	1.04
Prostate Epithelial Cells (polarized), donor1	11253-116F2	35.75	0.30	0.45	0.00	0.45
Prostate Epithelial Cells, donor2	11331-117E8	77.59	3.11	1.22	0.41	1.49
Prostate Epithelial Cells, donor3	11404-118D9	15.06	0.24	0.43	0.00	0.24
Prostate Stromal Cells, donor1	11254-116F3	46.36	0.11	0.46	0.11	0.46
Prostate Stromal Cells, donor2	11332-117E9	57.73	0.18	1.43	0.00	0.36
Prostate Stromal Cells, donor3	11405-118E1	23.98	0.73	0.73	0.10	0.73
Renal Cortical Epithelial Cells, donor1	11516-119H4	37.59	0.73	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	59.68	1.25	0.76	0.00	0.55
Renal Epithelial Cells, donor1	11517-119H5	63.40	0.00	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	66.15	0.00	0.00	0.00	2.13
Renal Epithelial Cells, donor3	11678-122H4	55.37	0.95	0.64	0.00	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	292.09	0.68	0.68	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	298.64	0.13	1.21	0.00	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	57.50	0.00	2.22	0.00	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	33.27	0.67	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	55.24	0.66	0.22	0.00	0.44
Renal Mesangial Cells, donor2	11598-120H5	55.17	0.00	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	40.78	0.00	1.11	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	45.63	0.27	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	45.96	0.00	0.84	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	53.03	0.39	1.74	0.00	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	54.97	0.52	0.52	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	29.56	0.00	0.00	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	43.22	0.00	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	41.65	0.00	0.75	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	21.11	0.94	0.13	0.00	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	37.52	1.79	0.89	0.00	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	28.07	0.00	0.55	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	28.42	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	48.24	0.39	0.91	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	33.86	0.30	0.99	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	40.93	0.00	0.45	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	53.59	0.00	0.74	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	39.97	0.47	0.47	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	53.16	0.46	1.62	0.00	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	59.56	0.00	0.55	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	37.06	0.00	1.51	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	46.23	0.36	0.18	0.00	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	61.40	0.14	0.29	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	68.68	0.64	1.72	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	48.68	0.00	0.44	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	54.10	0.19	0.76	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	60.56	0.37	0.75	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	32.88	0.00	0.00	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	61.58	0.13	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	54.41	0.19	0.39	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	43.73	0.00	0.19	0.19	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	59.59	0.21	0.11	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	41.49	0.28	0.56	0.00	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	41.02	0.00	1.71	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	65.46	0.18	0.55	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	40.84	0.12	1.35	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	53.33	0.00	1.21	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	71.94	0.00	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	47.62	0.40	0.99	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	55.42	0.23	0.94	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	72.99	0.41	0.83	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	69.68	0.44	2.21	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	45.54	0.00	0.42	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	62.85	0.13	0.40	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	63.52	0.00	0.17	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	42.22	0.00	1.35	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	51.58	0.17	1.20	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	58.85	0.14	0.27	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	55.16	0.00	1.48	0.00	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	51.64	0.00	1.02	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	80.93	0.00	0.74	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	40.25	0.00	0.27	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	35.26	0.14	0.28	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	77.86	0.48	0.95	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	37.29	0.40	0.60	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	53.02	0.19	0.85	0.00	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	35.63	0.00	1.40	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	23.87	0.00	0.30	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	60.21	0.37	0.61	0.12	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	18.49	0.15	0.29	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	35.90	0.61	0.61	0.00	3.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	80.47	0.60	1.21	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	35.06	0.23	0.68	0.00	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	31.45	1.20	0.90	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	33.18	0.24	1.42	0.00	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	30.31	0.21	0.85	0.43	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	36.66	0.00	1.20	0.00	0.00
Schwann Cells, donor1	11498-119F4	531.68	0.56	1.69	0.00	1.32
Schwann Cells, donor2	11578-120F3	78.26	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	29.80	0.44	1.10	0.00	1.10
Sebocyte, donor1	11220-116B5	161.59	0.55	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	16.08	0.00	0.92	0.00	1.84
Sebocyte, donor3	11378-118B1	26.38	0.62	0.82	0.00	0.41
Sertoli Cells, donor1	11255-116F4	104.37	4.97	4.97	0.00	1.66
Sertoli Cells, donor2	11333-117F1	172.29	8.47	2.82	0.00	5.65
Skeletal Muscle Cells, donor1	11281-116I3	31.23	0.88	0.18	0.00	0.00
Skeletal Muscle Cells, donor2	11358-117H8	30.36	1.45	1.45	0.72	2.89
Skeletal Muscle Cells, donor3	11430-118G8	1779.93	2.51	15.88	0.84	6.69
Skeletal Muscle Cells, donor4	11451-119A2	463.58	0.16	3.14	0.00	1.10
Skeletal Muscle Cells, donor5	11455-119A6	401.49	0.30	1.78	0.00	0.59
Skeletal Muscle Cells, donor6	11459-119B1	469.25	0.31	3.54	0.00	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	38.56	0.13	0.50	0.00	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	40.81	0.57	1.57	0.00	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	85.62	0.20	1.59	0.00	0.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	31.59	0.76	0.17	0.17	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	125.21	1.45	5.07	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	561.82	1.51	7.84	0.14	2.20
Skin - palm, donor1	10286-104F7	13.43	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	369.91	1.30	1.59	0.14	2.02
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	66.25	3.27	0.00	0.00	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	351.18	1.56	1.56	0.13	2.60
Small Airway Epithelial Cells, donor1	11256-116F5	60.75	1.53	0.42	0.00	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	45.85	0.84	1.41	0.00	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	41.02	1.27	0.85	0.21	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	22.86	0.90	0.45	0.15	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	204.59	7.41	4.32	0.93	3.39
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	72.26	1.11	0.44	0.44	1.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	110.51	2.35	1.76	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	68.51	2.87	0.44	0.66	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	96.87	1.58	0.39	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	129.02	3.86	1.55	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	42.03	2.00	1.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	105.66	2.26	0.93	0.80	1.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	73.15	2.88	3.32	0.44	2.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	775.10	3.97	5.89	0.64	2.18
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	35.16	0.00	0.65	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	21.56	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	31.46	0.43	0.57	0.00	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	44.57	0.33	0.33	0.00	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	25.88	0.00	0.91	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	103.05	2.78	2.27	0.00	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	97.93	12.24	0.00	12.24	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	190.73	8.58	10.01	0.95	3.81
Smooth Muscle Cells - Colonic, donor1	11239-116D6	30.08	0.00	0.29	0.00	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	40.46	0.00	2.15	0.00	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	56.47	0.42	1.05	0.00	0.94
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	92.81	1.24	0.93	0.46	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	232.82	8.62	9.70	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	606.08	2.39	3.89	0.30	2.09
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	69.99	0.00	0.34	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	50.49	1.33	0.31	0.24	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	68.74	5.33	0.30	0.81	1.21
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	88.52	2.50	1.14	0.00	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	274.73	4.83	14.49	0.60	4.23
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	57.75	0.26	0.53	0.00	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	221.31	1.60	0.13	0.13	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	44.70	0.75	1.50	0.00	1.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	18.77	0.76	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	62.87	1.36	0.45	0.15	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	115.53	8.25	1.50	0.00	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	51.69	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	144.17	13.95	2.33	0.93	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	141.37	3.53	1.51	1.01	2.52
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	688.53	3.76	9.40	0.31	2.82
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	31.86	0.88	0.29	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	81.47	0.25	0.08	0.00	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	24.29	0.47	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	141.47	3.74	1.30	0.86	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	112.44	3.57	4.84	0.51	1.78
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	1040.95	2.07	6.39	0.38	2.07
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	38.85	0.28	0.14	0.00	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	188.86	0.50	0.08	0.08	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	41.90	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	162.46	1.71	1.96	0.49	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	253.43	0.66	0.22	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	73.73	1.46	1.17	0.00	2.34
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	88.24	0.19	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	125.62	4.23	2.38	0.79	3.17
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	35.71	0.37	0.37	0.00	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	64.32	2.52	1.80	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	102.49	1.70	0.85	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	105.56	0.39	0.39	0.00	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	78.47	4.57	2.29	0.25	2.03
Smooth muscle cells - airway, control, donor2	11967-126D5	60.30	3.59	0.80	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	40.96	2.09	0.84	0.00	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	53.17	0.92	0.00	0.00	0.46
Synoviocyte, donor1	11291-117A4	65.81	0.67	0.50	0.50	1.18
Synoviocyte, donor2	11368-117I9	23.30	1.17	1.51	0.00	0.84
Synoviocyte, donor3	11440-118H9	97.41	0.89	0.89	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	70.39	0.36	0.00	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	37.66	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	89.61	0.69	0.69	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	44.09	0.65	0.57	0.07	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	51.41	0.77	2.32	0.00	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	81.89	1.72	5.73	0.00	2.86
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	17.35	1.35	0.49	0.00	0.25
Urethra, donor2	10319-105A4	12.59	0.00	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	81.56	1.06	1.06	0.00	0.00
Urothelial Cells, donor2	11600-120H7	50.07	0.40	1.20	0.00	0.80
Urothelial Cells, donor3	11681-122H7	54.55	1.83	1.15	0.00	0.92
Urothelial cells, donor0	11216-116B1	39.68	0.89	0.45	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	42.71	0.89	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	25.73	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	8.21	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	13.77	0.69	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	25.57	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	36.44	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	18.36	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	17.35	0.00	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	53.54	0.12	0.37	0.00	0.37
Wilms' tumor cell line:HFWT	10597-108E3	24.64	0.00	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	56.70	0.28	0.56	0.00	0.56
achilles tendon, donor2	10292-104G4	20.67	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	38.24	0.25	0.00	0.00	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	65.01	5.11	0.00	0.70	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	58.64	4.15	0.12	1.07	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	41.63	1.09	0.27	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	39.63	0.28	0.00	0.00	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	58.16	0.00	0.42	0.00	1.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	47.64	0.82	1.09	0.00	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	38.34	0.00	0.88	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	22.46	0.00	1.23	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	39.22	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	63.11	0.00	0.92	0.00	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	61.58	0.70	1.16	0.00	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	44.01	0.26	0.52	0.00	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	54.07	0.00	1.46	0.00	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	27.42	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	85.95	0.41	0.41	0.00	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	98.22	0.00	0.31	0.00	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	24.75	0.00	0.85	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	17.89	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	26.24	0.24	0.24	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	42.77	0.00	0.45	0.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	56.37	0.67	0.33	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	37.16	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	73.07	0.00	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	34.02	0.00	0.44	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	178.07	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	337.24	1.41	0.00	0.24	0.94
adipose tissue, adult, pool1	10010-101C1	15.20	0.47	0.16	0.00	0.31
adipose, donor1	10184-103D4	49.26	1.76	2.93	0.59	15.83
adipose, donor2	10185-103D5	45.82	12.98	2.03	2.43	37.71
adipose, donor3	10186-103D6	48.20	1.36	1.63	0.82	11.44
adipose, donor4	10187-103D7	39.87	1.73	0.00	0.87	5.20
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	89.33	4.42	0.63	0.32	0.32
adrenal gland, adult, pool1	10081-102A9	141.87	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	40.69	1.47	0.13	0.00	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	68.24	0.36	1.07	0.00	1.43
amniotic membrane cells, donor1	12235-129G3	428.46	3.48	1.85	0.23	1.62
amniotic membrane cells, donor2	12236-129G4	17.92	1.01	0.68	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	84.26	5.01	1.77	0.00	0.59
amygdala - adult, donor10196	10167-103B5	222.93	16.60	2.37	2.37	1.19
amygdala, adult, donor10252	10151-102I7	23.72	17.84	1.01	0.20	1.01
amygdala, newborn, donor10223	10360-105E9	56.48	10.65	0.65	0.97	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	29.16	2.16	0.25	0.13	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	1009.57	1.54	0.22	0.00	2.65
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	53.11	2.34	0.00	0.00	0.67
aorta, adult, pool1	10052-101G7	16.28	1.18	0.39	0.00	0.20
appendix, adult	10189-103D9	18.63	0.78	1.16	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	103.18	6.88	0.34	0.69	0.34
artery, adult	10190-103E1	28.53	1.36	6.79	0.00	5.43
astrocytoma cell line:TM-31	10425-106D2	42.59	1.59	0.14	0.14	0.29
b cell line:RPMI1788	10427-106D4	66.77	9.67	0.15	0.59	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	84.34	3.88	2.22	0.28	2.77
bile duct carcinoma cell line:HuCCT1	10432-106D9	81.47	0.20	0.40	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	20.25	0.17	0.33	0.00	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	29.08	0.00	0.00	0.00	0.56
bladder, adult, pool1	10011-101C2	19.12	2.17	0.00	0.00	0.54
blood, adult, pool1	10053-101G8	93.01	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	21.41	0.00	0.00	0.00	0.86
bone marrow, adult	10192-103E3	31.72	0.00	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	265.49	19.48	0.00	1.03	1.03
brain, adult, pool1	10012-101C3	39.42	10.69	0.33	1.00	0.67
brain, fetal, pool1	10085-102B4	245.77	13.36	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	35.02	0.99	0.66	0.00	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	16.85	1.50	0.00	0.12	0.00
breast, adult, donor1	10080-102A8	78.92	1.26	0.63	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	138.98	4.32	1.02	0.13	1.78
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	30.61	0.62	0.31	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	180.72	7.83	2.76	0.69	4.14
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	30.26	0.48	0.97	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	52.19	4.70	0.00	0.47	0.94
carcinoid cell line:NCI-H727	10735-110B6	161.55	0.55	0.00	0.00	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	82.39	9.19	0.63	1.27	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	99.55	1.86	1.60	0.53	1.33
caudate nucleus - adult, donor10196	10177-103C6	31.09	28.78	1.15	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	24.93	43.67	1.34	2.84	0.17
caudate nucleus, adult, donor10258	10379-105H1	12.99	61.90	0.00	6.11	0.76
caudate nucleus, newborn, donor10223	10354-105E3	56.77	36.62	0.37	5.13	0.73
cerebellum - adult, donor10196	10173-103C2	171.88	2.91	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	23.27	3.20	0.43	0.21	0.43
cerebellum, adult, pool1	10083-102B2	203.17	8.28	1.38	0.34	1.38
cerebellum, newborn, donor10223	10357-105E6	77.22	9.13	0.83	0.83	0.00
cerebral meninges, adult	10188-103D8	54.46	12.61	2.02	0.50	1.01
cerebrospinal fluid, donor2	10294-104G6	17.54	5.12	0.73	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	37.81	0.14	0.14	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	34.63	0.17	0.00	0.00	0.00
cervix, adult, pool1	10013-101C4	13.96	0.63	0.10	0.10	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	32.47	0.00	0.28	0.14	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	18.29	3.92	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	40.02	1.86	0.12	0.00	0.62
choriocarcinoma cell line:SCH	10785-110H2	113.60	4.19	0.49	0.12	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	45.54	0.47	0.00	0.00	0.47
chorionic membrane cells, donor1	12238-129G6	272.10	1.99	1.14	0.00	0.85
chorionic membrane cells, donor2	12239-129G7	163.76	0.20	0.60	0.10	0.40
chorionic membrane cells, donor3	12240-129G8	52.75	2.20	2.20	0.00	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	79.77	2.02	5.05	0.00	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	147.72	0.96	0.58	0.00	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	41.60	0.00	0.21	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	66.51	2.05	1.03	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	60.71	1.21	0.00	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	53.55	0.81	0.20	0.20	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	37.40	0.00	0.29	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	26.32	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	82.98	1.60	2.74	0.00	2.97
clear cell carcinoma cell line:TEN	10636-108I6	64.37	1.56	0.52	0.00	0.35
colon carcinoma cell line:CACO-2	10513-107D9	70.65	0.00	0.18	0.00	0.55
colon carcinoma cell line:COLO-320	10420-106C6	35.35	1.90	0.00	0.38	0.00
colon, adult, donor1	10082-102B1	242.77	0.00	2.38	0.00	2.38
colon, adult, pool1	10014-101C5	35.25	0.35	0.35	0.12	0.47
colon, fetal, donor1	10070-101I7	313.94	5.56	0.00	1.24	3.71
common myeloid progenitor CMP, donor1	12130-128D6	13.75	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	13.60	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	36.53	1.06	0.15	0.00	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	38.50	0.42	0.56	0.14	0.42
corpus callosum, adult, pool1	10042-101F6	16.36	2.87	0.00	0.11	0.22
cruciate ligament, donor2	10295-104G7	17.83	0.81	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	182.18	1.61	1.61	0.00	2.41
diencephalon, adult	10193-103E4	32.88	16.80	1.44	1.44	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	129.27	2.98	3.90	0.46	1.61
ductal cell carcinoma cell line:KLM-1	10438-106E6	96.68	0.26	0.26	0.00	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	53.92	0.72	0.24	0.00	0.00
ductus deferens, adult	10196-103E7	22.43	0.50	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	122.42	2.88	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	27.95	0.00	0.74	0.00	0.74
dura mater, adult, donor1	10041-101F5	15.61	0.91	0.25	0.00	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	78.61	0.89	1.78	0.22	3.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	90.56	0.57	0.86	0.29	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	19.12	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	22.40	0.00	0.00	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	20.07	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	11.82	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	26.48	0.00	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	25.92	0.36	0.18	0.00	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	89.41	0.80	2.73	0.16	1.29
epidermoid carcinoma cell line:A431	10426-106D3	24.12	0.78	0.00	0.00	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	85.13	1.65	0.33	0.22	0.33
epididymis, adult	10197-103E8	16.12	0.42	1.47	0.00	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	14.02	0.18	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	2.36	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	58.58	0.00	1.44	0.00	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	41.43	0.20	0.89	0.00	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	64.30	0.11	1.12	0.00	0.67
esophagus, adult, pool1	10015-101C6	28.77	1.06	0.21	0.00	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	18.28	1.38	0.13	0.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	12.07	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	0.00	4.21	0.00	0.00
eye - muscle medial, donor2	10299-104H2	14.88	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	14.90	0.00	0.00	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	34.98	7.29	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	633.55	6.10	3.05	1.27	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	194.13	0.51	0.26	0.00	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	124.65	2.61	1.19	0.24	1.90
frontal lobe, adult, pool1	10040-101F4	31.06	19.14	0.28	2.44	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	25.82	0.30	0.30	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	25.15	0.64	0.00	0.09	0.00
gall bladder, adult	10198-103E9	40.32	0.48	0.00	0.00	0.72
gamma delta positive T cells, donor1	11937-126A2	26.31	0.54	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	23.90	0.75	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	26.40	0.00	0.21	0.00	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	109.28	0.39	1.16	0.00	0.39
gastric cancer cell line:AZ521	10549-107H9	49.84	0.49	0.16	0.00	0.33
gastric cancer cell line:GSS	10560-108A2	12.81	2.75	0.00	0.00	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	48.89	0.46	1.60	0.23	0.91
giant cell carcinoma cell line:LU65	10487-107B1	25.36	0.11	0.11	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	22.11	0.84	0.00	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	26.69	0.50	0.25	0.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	17.73	0.63	0.00	0.00	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	14.18	0.14	0.00	0.00	0.28
glioblastoma cell line:T98G	10485-107A8	64.46	0.77	0.22	0.22	0.44
glioma cell line:GI-1	10413-106B8	15.52	0.88	0.00	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	23.33	17.49	0.00	1.46	0.73
globus pallidus, adult, donor10252	10161-103A8	22.70	8.79	0.49	0.00	0.24
globus pallidus, adult, donor10258	10367-105F7	26.01	5.48	0.00	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	65.55	19.19	1.60	1.07	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	31.81	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	63.68	2.56	1.28	0.00	0.64
hIPS +CCl2, biol_rep1	14383-156B9	95.50	2.30	0.92	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	84.14	1.83	0.91	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	116.58	1.93	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	773.26	0.00	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	165.98	2.06	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	43.04	9.93	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	69.54	5.75	1.15	0.00	1.15
heart - mitral valve, adult	10205-103F7	16.44	1.20	0.90	0.00	0.60
heart - pulmonic valve, adult	10206-103F8	13.07	0.00	0.52	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	24.15	2.50	1.67	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	28.16	0.00	1.02	0.00	1.02
heart, adult, diseased, donor1	10051-101G6	31.51	0.00	1.70	0.00	1.28
heart, adult, pool1	10016-101C7	26.22	0.23	0.23	0.00	0.69
heart, fetal, pool1	10046-101G1	34.81	0.41	0.21	0.21	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	111.69	2.47	1.23	0.31	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	41.62	1.19	2.38	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	54.36	0.77	0.99	0.33	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	56.32	0.61	0.85	0.00	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	64.47	1.52	1.21	0.20	0.20
hepatoma cell line:Li-7	10484-107A7	42.82	0.00	0.22	0.00	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	96.58	1.91	0.20	0.30	0.30
hippocampus - adult, donor10196	10169-103B7	37.85	10.41	0.95	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	20.82	11.02	1.02	0.20	0.41
hippocampus, adult, donor10258	10374-105G5	56.27	12.45	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	49.35	20.44	0.35	1.06	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	162.96	2.44	3.05	0.61	12.21
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	85.22	3.53	2.16	0.39	2.55
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	144.97	5.08	3.55	0.76	6.35
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	60.90	3.95	2.26	0.56	23.12
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	40.28	3.87	2.84	0.26	21.43
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	83.89	4.18	2.66	0.38	15.94
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	76.78	6.42	2.34	2.04	22.77
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	53.43	11.20	3.23	0.65	13.57
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	55.89	4.59	0.42	0.42	6.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	64.17	0.95	0.71	0.00	3.55
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	45.64	1.29	1.61	0.16	5.79
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	47.80	0.00	0.00	0.67	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	86.54	4.69	2.19	0.63	4.85
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	108.58	5.40	8.35	0.00	9.33
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	181.53	2.62	0.87	0.00	11.35
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	37.80	2.48	2.10	0.19	10.50
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	42.30	3.92	0.44	0.00	5.67
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	57.47	2.00	5.00	0.00	32.98
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	83.46	13.00	1.88	3.01	22.23
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	89.58	12.28	2.73	1.36	24.55
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	103.05	13.16	1.57	2.51	32.26
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	46.54	2.29	0.65	0.16	9.80
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	58.93	3.19	1.16	0.87	6.97
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	75.63	6.28	0.60	0.90	19.13
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	84.98	3.14	4.06	0.18	5.73
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	97.57	2.28	2.00	0.00	3.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	166.59	2.45	2.86	1.22	8.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	41.90	2.82	2.46	0.00	12.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	41.81	1.58	2.53	0.00	11.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	56.89	3.03	1.51	0.30	19.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	81.71	8.79	2.59	1.03	11.89
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	83.02	7.31	1.33	0.66	10.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	92.10	4.36	1.28	1.03	7.44
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	49.08	1.53	1.28	0.26	5.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	65.88	0.76	1.51	0.76	6.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	63.51	1.68	1.34	0.00	8.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	105.54	2.66	0.48	0.00	3.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	163.11	5.35	4.01	0.89	8.47
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	143.42	6.34	2.93	0.00	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	35.45	1.83	2.14	0.00	8.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	110.61	0.00	9.76	0.00	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	55.60	1.32	3.31	0.33	27.47
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	77.17	9.30	2.19	2.74	13.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	83.96	10.13	2.53	1.45	14.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	99.29	7.12	2.14	2.14	22.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	59.67	0.00	1.19	0.00	8.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	52.68	0.81	0.54	0.54	3.11
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	48.76	2.69	1.08	0.54	8.08
immature langerhans cells, donor1	11904-125F5	46.49	0.00	0.48	0.00	0.00
immature langerhans cells, donor2	11905-125F6	66.54	0.79	0.79	0.00	0.79
insula, adult, pool1	10039-101F3	34.35	20.25	0.28	1.51	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	257.19	0.00	0.00	0.00	0.65
kidney, adult, pool1	10017-101C8	28.94	0.20	0.40	0.00	0.70
kidney, fetal, pool1	10045-101F9	35.51	1.20	0.21	0.28	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	76.83	2.41	0.57	0.43	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	34.98	0.83	0.28	0.00	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	28.81	0.55	0.18	0.00	0.37
left atrium, adult, donor1	10079-102A7	118.23	0.00	0.00	0.00	1.09
left ventricle, adult, donor1	10078-102A6	105.18	0.00	1.52	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	288.11	0.55	0.27	0.00	0.82
leiomyoma cell line:10964C	10569-108B2	53.89	1.44	1.08	0.00	2.51
leiomyoma cell line:15242A	10570-108B3	67.94	1.09	2.72	0.00	1.09
leiomyoma cell line:15425	10571-108B4	52.21	0.49	2.43	0.24	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	30.32	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	55.96	0.00	0.24	0.00	0.47
liposarcoma cell line:KMLS-1	10782-110G8	50.14	2.03	0.47	0.16	0.78
liposarcoma cell line:SW 872	10726-110A6	344.93	0.97	0.61	0.00	0.12
liver, adult, pool1	10018-101C9	24.15	0.00	0.00	0.00	0.00
liver, fetal, pool1	10086-102B5	171.21	0.94	2.82	0.00	1.88
locus coeruleus - adult, donor10196	10182-103D2	23.04	2.19	0.44	0.15	0.29
locus coeruleus, adult, donor10252	10165-103B3	21.78	2.95	0.37	0.18	0.00
locus coeruleus, adult, donor10258	10375-105G6	211.89	6.49	0.56	0.28	1.69
locus coeruleus, newborn, donor10223	10362-105F2	39.96	5.05	0.00	0.84	0.42
lung adenocarcinoma cell line:A549	10499-107C4	37.23	0.55	0.00	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	41.36	1.38	0.00	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	197.20	1.45	0.53	0.00	0.66
lung, adult, pool1	10019-101D1	13.58	0.24	0.12	0.00	0.95
lung, fetal, donor1	10068-101I5	40.24	0.86	0.00	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	73.77	0.00	0.46	0.00	0.46
lymph node, adult, donor1	10077-102A5	142.48	0.00	0.00	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	857.64	4.16	1.53	0.44	1.53
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	28.83	0.30	0.30	0.15	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	31.43	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	34.63	0.44	1.33	0.00	0.44
mature adipocyte, donor2	12232-129F9	22.62	0.00	0.21	0.00	0.21
mature adipocyte, donor3	12233-129G1	25.60	0.00	0.24	0.00	0.00
mature adipocyte, donor4	12234-129G2	25.27	0.00	0.26	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	32.64	2.62	0.00	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	38.35	15.79	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	20.41	10.67	0.74	1.29	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	73.70	16.84	0.00	1.27	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	106.62	5.54	4.26	1.28	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	31.73	18.23	2.03	1.52	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	19.74	11.46	0.85	0.64	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	67.42	19.26	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	215.30	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	97.63	17.23	0.72	1.79	0.36
medulla oblongata - adult, donor10196	10174-103C3	131.09	1.95	0.65	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	17.34	2.17	0.77	0.00	0.31
medulla oblongata, adult, pool1	10038-101F2	18.20	2.29	0.00	0.41	0.24
medulla oblongata, newborn, donor10223	10361-105F1	61.80	2.78	1.39	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	43.84	0.22	0.44	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	68.60	0.37	0.24	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	37.52	0.57	0.29	0.14	0.86
melanoma cell line:G-361	10465-106H6	31.76	0.27	0.27	0.00	0.81
meningioma cell line:HKBMM	10691-109F7	36.90	1.09	2.71	0.00	1.45
merkel cell carcinoma cell line:MKL-1	10843-111E6	80.19	3.52	1.76	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	60.66	1.04	3.89	0.26	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	142.23	1.84	1.99	0.31	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	84.16	1.45	1.45	0.00	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	156.94	0.41	0.41	0.00	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	146.94	0.84	0.56	0.00	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	73.95	1.73	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	77.74	0.00	1.39	0.00	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	150.35	0.86	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	55.44	1.61	0.69	0.12	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	87.14	0.93	0.66	0.00	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	75.76	0.54	0.95	0.00	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	89.48	1.28	0.71	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	41.83	1.65	0.33	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	165.08	4.29	1.38	0.55	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	135.79	3.49	1.75	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	160.07	1.84	0.61	0.41	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	83.39	1.08	1.44	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	142.76	3.62	0.93	0.72	0.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	119.47	2.96	1.14	0.46	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	138.45	1.68	0.84	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	132.40	1.64	1.49	0.15	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	118.52	1.84	1.05	0.09	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	71.79	1.84	3.68	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	95.58	0.86	3.15	0.57	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	111.57	1.26	7.58	0.00	3.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	56.17	1.37	0.46	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	46.30	1.02	0.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	44.24	1.31	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	64.70	0.31	0.92	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	52.72	0.47	1.88	0.00	2.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	48.06	1.35	0.00	0.34	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	56.98	1.18	1.18	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	52.36	0.93	0.93	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	65.18	0.87	0.87	0.00	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	42.39	0.67	0.67	0.22	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	73.07	0.72	0.72	0.00	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	47.67	0.73	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	48.33	1.01	0.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	64.27	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	44.67	0.86	0.86	0.00	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	46.48	0.00	0.00	0.00	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	49.69	0.65	0.97	0.00	2.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	37.83	1.45	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	67.70	2.13	2.13	0.00	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	53.16	0.82	0.82	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	54.42	1.17	1.55	0.00	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	52.47	0.00	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	73.52	0.99	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	56.92	2.37	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	45.08	0.00	2.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	65.24	0.00	1.90	0.00	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	52.43	2.07	1.38	0.00	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	51.58	0.00	4.30	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	0.00	3.44	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	26.89	0.41	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	28.60	2.38	0.79	0.00	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	23.58	0.59	1.77	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	22.44	0.94	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	20.05	0.00	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	31.93	0.00	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	35.95	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	29.60	0.00	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	31.17	0.49	0.00	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	25.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	17.81	0.00	0.00	0.00	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	25.79	0.00	0.40	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	41.43	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	20.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	22.45	0.00	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	21.42	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	32.34	0.60	0.00	0.00	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	35.05	0.00	0.32	0.00	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	19.35	1.02	0.00	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	10.06	0.77	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	32.60	1.18	0.00	0.00	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	15.29	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	59.83	0.00	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	48.19	0.21	0.92	0.00	1.23
mesothelioma cell line:Mero-25	10850-111F4	33.59	0.23	0.45	0.00	1.13
mesothelioma cell line:Mero-41	10851-111F5	51.34	0.00	1.47	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	55.80	0.89	0.66	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	43.36	0.53	0.53	0.00	0.79
mesothelioma cell line:Mero-83	10854-111F8	43.92	0.17	0.51	0.17	0.34
mesothelioma cell line:Mero-84	10855-111F9	48.03	0.00	0.25	0.00	0.76
mesothelioma cell line:Mero-95	10856-111G1	31.26	0.00	0.00	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	45.88	0.66	0.66	0.17	0.33
mesothelioma cell line:NCI-H226	10846-111E9	45.61	1.27	0.72	0.00	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	46.12	0.34	0.85	0.00	0.34
mesothelioma cell line:NCI-H28	10845-111E8	108.40	1.53	2.04	0.00	1.53
mesothelioma cell line:No36	10857-111G2	63.28	0.00	0.33	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	75.05	0.00	0.27	0.00	1.90
migratory langerhans cells, donor1	11901-125F2	44.33	0.77	0.96	0.19	0.38
migratory langerhans cells, donor2	11902-125F3	37.00	0.37	0.73	0.00	0.37
migratory langerhans cells, donor3	11903-125F4	32.31	0.00	0.36	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	29.71	0.33	1.63	0.00	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	134.37	11.66	4.66	2.54	4.87
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	170.69	0.69	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	111.89	0.38	1.14	0.00	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	25.87	0.00	0.37	0.00	0.37
myeloma cell line:PCM6	10474-106I6	30.05	1.58	0.00	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	33.48	0.00	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	34.32	0.00	0.59	0.00	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	26.07	0.33	0.33	0.00	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	26.18	0.37	0.22	0.00	0.15
nasal epithelial cells, donor2	12227-129F4	12.14	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	27.15	0.46	0.23	0.00	0.69
neuroblastoma cell line:NB-1	10539-107G8	57.06	0.56	0.19	0.19	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	38.59	0.63	0.21	0.00	0.63
neuroblastoma cell line:NH-12	10555-107I6	33.54	2.42	0.75	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	25.62	0.00	0.71	0.00	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	61.77	3.33	1.43	0.16	1.74
neuroectodermal tumor cell line:TASK1	10774-110F9	266.47	0.20	0.60	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	151.95	2.54	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	80.38	2.13	0.80	0.00	1.60
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	44.14	3.38	0.34	0.51	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	86.45	0.00	0.80	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	32.06	3.53	0.00	0.32	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	33.37	1.84	1.31	0.00	1.58
nucleus accumbens, adult, pool1	10037-101F1	24.09	25.40	0.00	2.81	0.00
occipital cortex - adult, donor10196	10172-103C1	185.43	10.30	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	15.03	7.78	0.54	0.00	0.54
occipital cortex, newborn, donor10223	10355-105E4	84.43	19.65	1.46	1.09	0.36
occipital lobe, adult, donor1	10076-102A4	253.48	17.84	1.31	0.52	1.57
occipital lobe, fetal, donor1	10073-102A1	104.27	4.29	0.86	0.00	2.15
occipital pole, adult, pool1	10036-101E9	40.60	16.24	0.16	1.42	0.08
olfactory region, adult	10195-103E6	29.23	12.04	1.91	0.76	0.38
optic nerve, donor1	10277-104E7	18.01	4.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	31.55	1.59	0.11	0.00	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	67.59	1.24	0.00	0.00	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	32.17	0.17	1.52	0.00	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	33.96	0.12	0.23	0.00	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	39.39	2.35	0.88	0.29	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	30.83	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	27.36	0.64	0.21	0.00	0.42
ovary, adult, pool1	10020-101D2	20.61	1.40	0.17	0.09	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	102.66	4.95	0.92	0.00	1.47
pancreas, adult, donor1	10049-101G4	101.59	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	29.07	0.56	0.00	0.00	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	56.39	0.00	2.38	0.00	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	14.57	0.00	0.00	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	30.93	15.01	0.46	1.28	0.09
parietal cortex, adult, donor10258	10373-105G4	29.36	16.15	0.00	4.40	0.73
parietal lobe - adult, donor10196	10171-103B9	38.56	10.35	0.00	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	27.93	9.69	1.14	0.29	0.29
parietal lobe, adult, pool1	10034-101E7	48.03	12.69	0.26	1.23	0.26
parietal lobe, fetal, donor1	10072-101I9	28.13	6.79	0.00	0.00	2.91
parietal lobe, newborn, donor10223	10356-105E5	94.59	15.70	0.37	1.50	0.75
parotid gland, adult	10199-103F1	18.50	0.00	0.00	0.00	0.62
penis, adult	10200-103F2	19.87	1.07	1.61	0.00	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	22.31	0.56	0.56	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	210.09	1.02	0.44	0.15	0.87
pineal gland - adult, donor10196	10179-103C8	23.87	3.23	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	22.50	0.00	0.00	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	11.91	0.63	0.00	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	15.18	1.01	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	10.94	1.56	0.00	0.00	1.04
pituitary gland, adult, donor10258	10378-105G9	3.40	0.00	0.00	0.00	0.85
placenta, adult, pool1	10021-101D3	19.24	0.43	0.11	0.00	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	53.24	4.90	0.53	0.26	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	38.13	3.11	0.16	0.62	0.93
pons, adult, pool1	10033-101E6	26.85	4.73	0.09	0.69	0.09
postcentral gyrus, adult, pool1	10032-101E5	52.83	19.53	0.35	1.83	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	8.37	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	46.03	1.89	0.73	0.29	0.58
prostate cancer cell line:PC-3	10439-106E7	42.29	0.54	0.00	0.00	0.18
prostate, adult, pool1	10022-101D4	13.60	0.63	0.09	0.09	0.00
putamen, adult, donor10196	10176-103C5	32.34	38.95	0.71	2.83	0.94
putamen, adult, donor10252	10152-102I8	25.49	54.90	3.92	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	42.62	10.93	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	87.95	46.39	0.00	2.66	0.00
putamen, newborn, donor10223	10365-105F5	35.23	12.74	0.75	5.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	18.33	0.58	0.00	0.00	0.58
rectum, fetal, donor1	10067-101I4	182.22	0.00	1.39	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	42.19	1.27	0.64	0.21	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	59.65	8.28	0.41	0.83	1.66
retina, adult, pool1	10030-101E3	30.12	1.49	0.00	0.00	0.10
retinoblastoma cell line:Y79	10475-106I7	80.80	4.42	0.26	0.26	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	303.68	0.86	0.37	0.12	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	41.62	0.56	0.00	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.95	1.52	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	16.99	0.16	0.00	0.00	0.00
salivary acinar cells, donor2	11772-123I8	11.43	0.41	0.14	0.00	0.00
salivary acinar cells, donor3	11773-123I9	7.94	1.99	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	27.45	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	23.86	0.84	0.00	0.00	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	19.87	0.47	0.24	0.00	0.24
seminal vesicle, adult	10201-103F3	16.93	0.00	1.06	0.00	3.70
serous adenocarcinoma cell line:JHOS-2	10639-108I9	37.41	0.24	0.49	0.00	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	56.62	1.26	1.51	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	114.40	2.01	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	32.24	0.54	0.40	0.00	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	43.33	0.22	0.11	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	78.96	0.52	0.13	0.13	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	29.08	0.71	0.71	0.00	2.13
skeletal muscle, adult, pool1	10023-101D5	30.46	1.80	0.36	0.12	0.60
skeletal muscle, fetal, donor1	10066-101I3	305.52	9.05	3.02	1.01	3.02
skin, adult, donor1	10074-102A2	94.99	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	20.83	1.26	1.26	0.00	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	664.38	1.33	0.67	0.00	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	41.92	1.58	0.63	0.00	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	33.92	1.54	0.77	0.19	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	44.34	0.49	0.16	0.00	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	71.26	2.90	1.29	0.00	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	20.92	0.00	0.00	0.00	0.22
small intestine, adult, pool1	10024-101D6	43.84	0.60	0.36	0.12	0.36
small intestine, fetal, donor1	10064-101I1	21.62	0.00	0.74	0.00	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	78.99	0.00	2.56	0.00	1.03
smooth muscle, adult, pool1	10048-101G3	11.11	0.00	0.26	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	38.86	0.27	0.00	0.27	0.54
spinal cord - adult, donor10196	10181-103D1	15.37	2.75	0.23	0.46	0.46
spinal cord, adult, donor10252	10159-103A6	21.68	1.58	0.00	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	30.44	0.69	0.69	0.00	1.38
spinal cord, fetal, donor1	10056-101H2	21.34	1.83	1.83	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	51.89	0.00	0.46	0.00	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	100.96	2.84	0.45	0.15	0.15
spleen, adult, pool1	10025-101D7	16.30	0.44	0.22	0.00	0.33
spleen, fetal, pool1	10044-101F8	25.98	0.48	0.32	0.00	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	58.90	5.18	0.31	0.62	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	24.68	0.76	0.00	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	64.30	0.35	0.70	0.00	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	38.31	0.78	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	45.59	1.80	0.45	0.11	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	18.21	0.42	0.00	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	7.62	0.85	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	22.43	0.00	2.14	0.00	1.07
submaxillary gland, adult	10202-103F4	17.66	0.00	1.14	0.00	2.28
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	21.19	1.04	0.21	0.21	0.83
substantia nigra, adult, donor10258	10371-105G2	48.10	4.14	0.52	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	72.07	6.36	0.00	0.71	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	43.10	0.46	0.23	0.00	0.46
temporal lobe, adult, pool1	10031-101E4	57.98	23.99	0.34	2.12	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	12.82	4.27	0.00	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	22.42	7.03	1.32	0.44	0.88
tenocyte, donor1	11763-123H8	26.53	0.70	1.75	0.00	0.35
tenocyte, donor2	11765-123I1	20.22	0.76	0.38	0.00	0.00
tenocyte, donor3	11768-123I4	35.21	1.11	1.11	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	134.78	5.27	1.02	0.34	2.89
teratocarcinoma cell line:NCR-G1	10798-110I6	200.39	1.54	1.23	0.00	2.16
teratocarcinoma cell line:PA-1	10807-111A6	247.65	2.48	0.00	0.31	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	404.71	2.16	0.25	0.25	2.03
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	128.96	4.16	0.38	0.00	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	68.71	3.05	0.98	0.00	1.09
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	288.57	5.86	10.42	0.65	5.86
testis, adult, pool1	10026-101D8	24.05	3.76	0.32	0.75	0.43
testis, adult, pool2	10096-102C6	14.43	2.71	1.80	0.00	0.45
thalamus - adult, donor10196	10168-103B6	59.62	6.62	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	20.32	8.75	0.16	0.63	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	113.93	6.16	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	219.86	11.20	0.99	0.33	1.65
thalamus, newborn, donor10223	10366-105F6	99.53	2.88	1.73	0.00	1.73
throat, adult	10209-103G2	13.23	0.25	3.00	0.00	2.00
throat, fetal, donor1	10061-101H7	87.45	0.30	0.91	0.00	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	93.80	8.35	0.60	0.20	1.19
thymus, adult, pool1	10027-101D9	13.12	2.98	0.30	0.30	0.30
thymus, fetal, pool1	10043-101F7	24.00	3.53	0.00	0.62	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	90.15	1.60	0.40	0.00	2.13
thyroid carcinoma cell line:TCO-1	10783-110G9	213.59	0.28	0.28	0.00	0.28
thyroid, adult, pool1	10028-101E1	22.21	0.09	0.19	0.00	0.28
thyroid, fetal, donor1	10060-101H6	17.14	0.53	0.53	0.00	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	27.72	3.08	0.00	0.00	3.08
tongue, adult	10203-103F5	36.28	0.93	4.65	0.00	2.56
tongue, fetal, donor1	10059-101H5	212.42	1.18	2.36	0.00	2.36
tonsil, adult, pool1	10047-101G2	24.24	1.00	0.30	0.20	0.30
trachea, adult, pool1	10029-101E2	33.13	1.06	0.41	0.08	0.25
trachea, fetal, donor1	10058-101H4	23.85	1.54	1.54	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	54.56	0.00	1.06	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	19.66	0.00	0.00	0.00	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	46.69	0.47	0.16	0.00	0.78
tridermal teratoma cell line:HGRT	10694-109G1	20.93	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	161.34	0.42	0.17	0.00	0.17
umbilical cord, fetal, donor1	10057-101H3	22.95	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	15.19	0.51	0.00	0.00	0.17
uterus, fetal, donor1	10055-101H1	44.54	6.66	1.02	0.51	1.02
vagina, adult	10204-103F6	15.51	1.94	0.65	0.00	0.00
vein, adult	10191-103E2	15.12	0.66	0.66	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	66.23	5.34	0.27	0.00	0.53